HRP20020173B1 - Veterinary formulation for administration of a water-insoluble drug to a target animal through a water distribution system - Google Patents

Veterinary formulation for administration of a water-insoluble drug to a target animal through a water distribution system

Info

Publication number
HRP20020173B1
HRP20020173B1 HR20020173A HRP20020173A HRP20020173B1 HR P20020173 B1 HRP20020173 B1 HR P20020173B1 HR 20020173 A HR20020173 A HR 20020173A HR P20020173 A HRP20020173 A HR P20020173A HR P20020173 B1 HRP20020173 B1 HR P20020173B1
Authority
HR
Croatia
Prior art keywords
water
administration
distribution system
target animal
insoluble drug
Prior art date
Application number
HR20020173A
Inventor
Frank Ekhart Peter
Van Wandelen Mario
Matthijs Jetten Jan
Original Assignee
Janssen Pharmaceutica N.V.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica N.V. filed Critical Janssen Pharmaceutica N.V.
Publication of HRP20020173A2 publication Critical patent/HRP20020173A2/en
Publication of HRP20020173B1 publication Critical patent/HRP20020173B1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • Biophysics (AREA)
  • Inorganic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Colloid Chemistry (AREA)
  • Fodder In General (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
HR20020173A 1999-09-03 2002-02-26 Veterinary formulation for administration of a water-insoluble drug to a target animal through a water distribution system HRP20020173B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP99202876 1999-09-03
PCT/NL2000/000596 WO2001017504A1 (en) 1999-09-03 2000-08-28 Veterinary formulation for administration of a water-insoluble drug to a target animal through a water distribution system

Publications (2)

Publication Number Publication Date
HRP20020173A2 HRP20020173A2 (en) 2004-04-30
HRP20020173B1 true HRP20020173B1 (en) 2005-02-28

Family

ID=8240608

Family Applications (1)

Application Number Title Priority Date Filing Date
HR20020173A HRP20020173B1 (en) 1999-09-03 2002-02-26 Veterinary formulation for administration of a water-insoluble drug to a target animal through a water distribution system

Country Status (35)

Country Link
US (1) US9040571B2 (en)
EP (1) EP1214052B1 (en)
JP (1) JP4754139B2 (en)
KR (1) KR100702540B1 (en)
CN (1) CN1165289C (en)
AR (1) AR025470A1 (en)
AT (1) ATE273000T1 (en)
AU (1) AU775216B2 (en)
BG (1) BG65673B1 (en)
BR (1) BR0013754A (en)
CA (1) CA2383164C (en)
CZ (1) CZ301938B6 (en)
DE (1) DE60012947T2 (en)
EA (1) EA004785B1 (en)
EE (1) EE05052B1 (en)
ES (1) ES2226914T3 (en)
HK (1) HK1049628B (en)
HR (1) HRP20020173B1 (en)
HU (1) HU229311B1 (en)
IL (2) IL148438A0 (en)
MA (1) MA25432A1 (en)
ME (1) ME00132B (en)
MX (1) MXPA02002360A (en)
MY (1) MY128072A (en)
NZ (1) NZ517024A (en)
PL (1) PL201484B1 (en)
PT (1) PT1214052E (en)
RS (1) RS50341B (en)
SI (1) SI1214052T1 (en)
SK (1) SK285825B6 (en)
TR (1) TR200200532T2 (en)
TW (1) TWI234468B (en)
UA (1) UA72933C2 (en)
WO (1) WO2001017504A1 (en)
ZA (1) ZA200201708B (en)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050038022A1 (en) * 2001-03-26 2005-02-17 Unisearch Limited Method for treatment of cancer and compositions for use therein
CA2616512A1 (en) 2005-07-28 2007-02-08 Intervet International B.V. Novel benzimidazole (thio) carbamates with antiparasitic activity and the synthesis thereof
EP2037914B1 (en) 2006-06-14 2013-10-23 Intervet International BV A suspension comprising benzimidazole carbamate and a polysorbate
AR077320A1 (en) 2009-07-20 2011-08-17 Intervet Int Bv METHOD FOR THE PREPARATION OF CEFQUINOMA PARTICLES AND PHARMACEUTICAL FORMULATIONS THAT UNDERSTAND THEM.
EP2409683A1 (en) 2010-07-06 2012-01-25 KRKA, D.D., Novo Mesto Stable aqueous formulations comprising poorly water soluble active ingredients
RU2522267C2 (en) * 2012-08-28 2014-07-10 Федеральное государственное бюджетное образовательное учреждение высшего профессионального образования Курская государственная сельскохозяйственная академия имени профессора И.И. Иванова Министерства сельского хозяйства Российской Федерации Fenbendazole encapsulation method
RU2522229C1 (en) * 2013-03-26 2014-07-10 Федеральное государственное бюджетное образовательное учреждение высшего профессионального образования "Юго-Западный государственный университет" (ЮЗ ГУ) Fenbendazole encapsulation method
RU2545742C2 (en) * 2013-07-23 2015-04-10 Александр Александрович Кролевец Lactobifadol encapsulation method
RU2555782C1 (en) * 2014-03-03 2015-07-10 Александр Александрович Кролевец Method of producing glucosamine sulphate nanocapsules in konjac gum in hexane
RU2555055C1 (en) * 2014-03-18 2015-07-10 Александр Александрович Кролевец Method of obtaining nanocapsules of glucoamine sulphate in xanthan gum
RU2558084C1 (en) * 2014-03-18 2015-07-27 Александр Александрович Кролевец Method of producing aspirin nanocapsules in carrageenan
RU2557941C1 (en) * 2014-03-20 2015-07-27 Александр Александрович Кролевец Method of production of nanocapsules of aspirin in sodium alginate
RU2554759C1 (en) * 2014-04-07 2015-06-27 Александр Александрович Кролевец Method of obtaining potassium losartan nanocapsules
ES2925656T3 (en) * 2016-04-29 2022-10-19 Rousselot B V Protein-based excipient for active pharmaceutical ingredients
CN110151692A (en) * 2019-06-21 2019-08-23 石家庄九鼎动物药业有限公司 A kind of antiparasite drugs for animals Albendazole suspension preparation method
CN110693830B (en) * 2019-10-10 2021-09-17 华中农业大学 Veterinary oxfendazole nano suspension and preparation method thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2336931A1 (en) * 1975-12-30 1977-07-29 Dick Pierre Anthelmintic compsns. contg. benzimidazole deriv(s). - and other anthelmintic(s), with extended activity against digestive tract parasites
US5538989A (en) * 1993-11-10 1996-07-23 Hoechst-Roussel Agri-Vet Company Fenbendazole formulations
NZ260018A (en) * 1994-03-03 1995-10-26 Bomac Lab Ltd Benzimidazole compositions and anthelmintic compositions

Also Published As

Publication number Publication date
SK285825B6 (en) 2007-09-06
EP1214052B1 (en) 2004-08-11
ZA200201708B (en) 2003-08-27
MEP9108A (en) 2010-06-10
EE200200094A (en) 2003-04-15
ATE273000T1 (en) 2004-08-15
DE60012947D1 (en) 2004-09-16
YU14302A (en) 2004-11-25
MA25432A1 (en) 2002-04-01
CA2383164C (en) 2008-07-08
AR025470A1 (en) 2002-11-27
HRP20020173A2 (en) 2004-04-30
EA200200325A1 (en) 2002-08-29
IL148438A (en) 2006-12-10
PT1214052E (en) 2004-12-31
BG65673B1 (en) 2009-06-30
WO2001017504A1 (en) 2001-03-15
US20090062362A1 (en) 2009-03-05
RS50341B (en) 2009-11-10
HUP0202686A3 (en) 2004-06-28
EE05052B1 (en) 2008-08-15
EP1214052A1 (en) 2002-06-19
DE60012947T2 (en) 2005-08-25
PL353481A1 (en) 2003-11-17
SI1214052T1 (en) 2005-02-28
HUP0202686A2 (en) 2004-05-28
AU775216B2 (en) 2004-07-22
KR100702540B1 (en) 2007-04-04
TR200200532T2 (en) 2002-07-22
ME00132B (en) 2010-10-10
JP2003508482A (en) 2003-03-04
BG106448A (en) 2002-09-30
SK2642002A3 (en) 2002-12-03
MY128072A (en) 2007-01-31
TWI234468B (en) 2005-06-21
PL201484B1 (en) 2009-04-30
KR20020063844A (en) 2002-08-05
MXPA02002360A (en) 2002-07-30
BR0013754A (en) 2002-05-21
HK1049628A1 (en) 2003-05-23
CZ2002630A3 (en) 2002-09-11
CA2383164A1 (en) 2001-03-15
CZ301938B6 (en) 2010-08-04
US9040571B2 (en) 2015-05-26
EA004785B1 (en) 2004-08-26
AU7322900A (en) 2001-04-10
CN1372462A (en) 2002-10-02
NZ517024A (en) 2003-05-30
HU229311B1 (en) 2013-10-28
IL148438A0 (en) 2002-09-12
CN1165289C (en) 2004-09-08
UA72933C2 (en) 2005-05-16
ES2226914T3 (en) 2005-04-01
JP4754139B2 (en) 2011-08-24
HK1049628B (en) 2005-05-13

Similar Documents

Publication Publication Date Title
HRP20020173A2 (en) Veterinary formulation for administration of a water-insoluble drug to a target animal through a water distribution system
IL139229A0 (en) Drug delivery system comprising a tightly compacted solid medicament stock
DE60013445D1 (en) PHARMACEUTICAL DOSAGE FORM FOR CONTROLLED PULSATING DELIVERY
TW429154B (en) A controlled release formulation for poorly soluble basic drugs
AU2879100A (en) Formulation and system for intra-oral delivery of pharmaceutical agents
IL180449A0 (en) Pharmaceutical formulations comprising a waterinsoluble complex for sustained drug delivery
ATE279186T1 (en) SUSTAINED-RELEASE PHARMACEUTICAL FORM CONTAINING TRAMADOL ACCHARINATE
IL140761A0 (en) Sustained release pharmaceutical preparation
EP1091732A4 (en) Effervescent drug delivery system for oral administration
EP1231864A4 (en) Drug delivery catheters that attach to tissue and methods for their use
ATE245414T1 (en) ORAL ADMINISTERED SYSTEM FOR TEMPORAL AND SPATIAL CONTROLLED MEDICINAL DELIVERY
DE60020501D1 (en) Trimetazidine-containing matrix tablet for prolonged release of active ingredient after oral administration
UA66812C2 (en) Drug formulation with controlled release of active ingredient
EP1047435A4 (en) The use of an aqueous solution in the preparation of a medicament for use in the treatment of live animals
ZA981354B (en) Aqueous pharmaceutical composition comprising an active ingredient which is highly insoluble in water
DK1214052T3 (en) Veterinary formulation for administration of a water-insoluble drug to a target animal via a water distribution system
GB9801142D0 (en) Administration of beneficial substances to ruminant animals
AU1581795A (en) Lure for facilitating the administration of drugs to certain animals, particularly dogs
FR2796807B1 (en) CONTROLLED DISPENSING SYSTEM OF A LIQUID FOOD TO A GROUP OF ANIMALS
FR2799977B1 (en) PHARMACEUTICAL INJECTION SYSTEM WITH MEANS FOR NEUTRALIZATION OF THE NEEDLE AFTER USE
CO4910116A1 (en) CONTROLLED RELEASE FORMULATION FOR BASIC PHARMACS SLIMMY SOLUBLE
AU2917800A (en) Cannula for artificial insemination of hogs
GT199700078A (en) CONTROLLED RELEASE FORMULATION FOR BASIC PHARMACS SLIMMY SOLUBLE
IL149853A0 (en) Gastroretentive controlled release pharmaceutical dosage forms
GB2399270B (en) System of hysteroscopic insemination of animals

Legal Events

Date Code Title Description
A1OB Publication of a patent application
ARAI Request for the grant of a patent on the basis of the submitted results of a substantive examination of a patent application
B1PR Patent granted
PPPP Transfer of rights

Owner name: ELANCO ANIMAL HEALTH IRELAND LIMITED, IE

ODRP Renewal fee for the maintenance of a patent

Payment date: 20160812

Year of fee payment: 17

PBON Lapse due to non-payment of renewal fee

Effective date: 20170828